Physician

Elizabeth Michelle Gunderson, MD

According to 2025 Medicare claims, Elizabeth Gunderson, MD (NPI: 1053401745) practices hematology/oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is CANCER CARE NORTHWEST CENTERS P S (NPI: 1922072081; TIN: 911007627) and primary practice location at 99216-1020. Gunderson is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Gunderson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 356 traditional Medicare patients, billed 121,694 HCPCS/CPT codes, and received $2,144,843 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 723 prescription claims across 125 beneficiaries totaling $1,634,241 in drug costs, led by Verzenio (Abemaciclib). 2023 DME data shows 13 claims. Open Payments data shows 31 records totaling $552,704. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $77,128 to $2,144,843. Similarly, Part D prescription costs have risen steadily, from $183,443 to $1,634,241. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,058 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $77,128 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $79,481 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $22,852 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $17,033 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $421,382 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,791,736 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,673,362 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,091,826 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,206,626 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,144,843 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152582,354$77,128
20162652,241$79,481
201794371$22,852
201884251$17,033
201927234,444$421,382
2020506143,154$1,791,736
2021566304,668$3,673,362
2022518209,105$3,091,826
2023515219,691$3,206,626
2024356121,694$2,144,843

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$817K$1.6M2015 Drug cost: $183,443 (USD; Tot_Drug_Cst)2016 Drug cost: $304,434 (USD; Tot_Drug_Cst)2017 Drug cost: $313,856 (USD; Tot_Drug_Cst)2018 Drug cost: $142,141 (USD; Tot_Drug_Cst)2019 Drug cost: $229,345 (USD; Tot_Drug_Cst)2020 Drug cost: $556,058 (USD; Tot_Drug_Cst)2021 Drug cost: $812,559 (USD; Tot_Drug_Cst)2022 Drug cost: $726,637 (USD; Tot_Drug_Cst)2023 Drug cost: $1,201,238 (USD; Tot_Drug_Cst)2024 Drug cost: $1,634,241 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201590618$183,443
201688645$304,434
2017112478$313,856
201880289$142,141
201983236$229,345
2020168716$556,058
2021170865$812,559
2022140643$726,637
2023151802$1,201,238
2024125723$1,634,241

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.4K$8.7K2018 Medicare payment: $1,852 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,479 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,703 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $5,120 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $997 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R11$1,852
2019N/RN/RN/R
20201446$4,479
202113142$8,703
2022N/R107$5,120
2023N/R13$997
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more107283$137
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more97121$93
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's91162$12
36415Insertion of needle into vein for collection of blood sample119325$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count112317$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VerzenioAbemaciclib14392$202,611
IbrancePalbociclib12336$195,620
EverolimusEverolimus14390$32,870
XareltoRivaroxaban20651$12,077
EliquisApixaban15448$9,023

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$447AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.9$552,257AstraZeneca UK Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Elizabeth Michelle Gunderson, MD?

Tedicare shows public-source Medicare data for Elizabeth Michelle Gunderson, MD (NPI 1053401745), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth Michelle Gunderson, MD have ACO affiliation data?

Elizabeth Michelle Gunderson, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Elizabeth Michelle Gunderson, MD?

Elizabeth Michelle Gunderson, MD is linked to CANCER CARE NORTHWEST CENTERS P S (billing NPI 1922072081) in the available physician profile data.

Does Elizabeth Michelle Gunderson, MD have Open Payments data?

Elizabeth Michelle Gunderson, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.